New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065. (Q43991047)

28 November 2017

title

New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065. (English)

1 reference

28 November 2017

0 references

Feng Bai

1

1 reference

28 November 2017

Mark N Kirstein

series ordinal

2

1 reference

28 November 2017

Suzan K Hanna

series ordinal

3

1 reference

28 November 2017

Clinton F Stewart

series ordinal

4

1 reference

28 November 2017

publication date

1 June 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

28 November 2017

published in

1 reference

28 November 2017

volume

772

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

257-265

1 reference

describes a project that uses

28 November 2017

electrochemical detection

1 reference

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Can WR-2721 be improved upon?

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of WR-2721.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Measurement of WR-2721, WR-1065, and WR-33278 in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Human pharmacokinetics of WR-2721

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of amifostine and its metabolites in patients

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

10.1016/S1570-0232(02)00104-6

Identifiers

DOI

1 reference

28 November 2017

1 reference